Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Renee Wright-Michaud"'
Autor:
Thomas Lee, Thomas Barnes, Robert Mabry, Ashley Wong, Chris Wright, David Soto, Kevin Kauffman, Amy Becker, Alex Wesselhoeft, Allen Horhata, Akinola Emmanuel, Akshi Thakkar, Ramya Elangovan, Magnolia Chinn, Sharmistha Kundu, Kristen Ott, Trent Stevens, Yessica Wiryawan, Ian Langer, Rahul Vungutur, Corey Ciullo, Nelson Chau, Renee Wright-Michaud, Meghan Richardson, Jui Dutta-Simmons, Rena Schindler, Junghoon Yang, Paisley Haskell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2a5fc66995454ea9991f85952f8b8513
Autor:
Diana I. Albu, Zichun Wang, Kuan-Chun Huang, Jiayi Wu, Natalie Twine, Sarah Leacu, Christy Ingersoll, Lana Parent, Winnie Lee, Diana Liu, Renee Wright-Michaud, Namita Kumar, Galina Kuznetsov, Qian Chen, Wanjun Zheng, Kenichi Nomoto, Mary Woodall-Jappe, Xingfeng Bao
Publikováno v:
OncoImmunology, Vol 6, Iss 8 (2017)
Reprogramming of immunosuppressive tumor microenvironment (TME) by targeting alternatively activated tumor associated macrophages (M2TAM), myeloid-derived suppressor cells (MDSC), and regulatory T cells (Tregs), represents a promising strategy for de
Externí odkaz:
https://doaj.org/article/0ad9b21d212e459193839200090fcdbd
Autor:
Renee Wright-Michaud, Sarah Leacu, Jiayi Wu, Xingfeng Bao, Diana I. Albu, Mary Woodall-Jappe, Galina Kuznetsov, Diana Liu, Zichun Wang, Namita Kumar, Natalie C. Twine, Qian Chen, Lana Parent, Christy Ingersoll, Wanjun Zheng, Winnie Lee, Kenichi Nomoto, Kuan-Chun Huang
Publikováno v:
OncoImmunology, Vol 6, Iss 8 (2017)
Oncoimmunology
Oncoimmunology
Reprogramming of immunosuppressive tumor microenvironment (TME) by targeting alternatively activated tumor associated macrophages (M2TAM), myeloid-derived suppressor cells (MDSC), and regulatory T cells (Tregs), represents a promising strategy for de
Autor:
Galina Kuznetsov, Jiayi Wu, Mary Woodall-Jappe, Shanqin Xu, Renee Wright-Michaud, Xingfeng Bao, Diana I. Albu, Kuan-chung Huang
Publikováno v:
Molecular Cancer Therapeutics. 14:B198-B198
E7046 is a potent and selective small molecule antagonist of the type 4 prostaglandin E2 (PGE2) receptor EP4. The discovery and evaluation of this novel EP4 antagonist for cancer treatment was recently presented at the AACR 2015 annual conference (ab